A meta-analysis performed by Shu et al. [61] on 14 studies investigated the association between FGFR4 rs351855 polymorphism and various cancer risks indicated a significant association between this SNP and risk of overall cancer in all heterozygous, homozygous, dominant, recessive, and allele tested genetic models. Here, FGFR4 is linked to cancer.